Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
MERRIMACK PHARM (NQ: MACK)
5.520 USD  +0.040 (+0.73%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 5.540
Bid (Size) 5.520 (5900)
Ask (Size) 5.530 (1800)
Prev. Close 5.480
Today's Range 5.470 - 5.650
52wk Range 4.060 - 11.11
Shares Outstanding 96,087,920
Dividend Yield N/A
Top News
More News
Singh's TPG-Axon Shows New Stake in Agilent (A), Express Scripts (ESRX), FMC (FMC) (more...)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8341315 for the full story. Read More
from StreetInsider.com News Articles
Merrimack Reports First Quarter 2013 Financial Results
May 13, 2013
MM-398 Phase 3 (NAPOLI-1) Top Line Results and Several MM-121 Phase 2 Top Line Results Expected in Second Half of 2013 Read More
from GlobeNewswire News Releases

More News
Read More
Earnings Scheduled For May 13, 2013
May 13, 2013
category Earnings , Benzinga , VELT , and 39 more.
from Latest Articles from Benzinga.com
Stocks Hitting 52-Week Lows
May 06, 2013
category Benzinga , EBR , 52/Week Lows , and 7 more.
from Latest Articles from Benzinga.com
Merrimack to Present at Multiple Investor Conferences This Spring
May 02, 2013
from GlobeNewswire News Releases
Merrimack Pharmaceuticals Announces Timing of First Quarter 2013 Investor Conference Call
April 30, 2013
from GlobeNewswire News Releases
Merrimack Pharmaceuticals Completes Enrollment of Second Cohort in Phase 2 Study of MM-121 in Non-Small Cell Lung Cancer
April 29, 2013
from GlobeNewswire News Releases
Merrimack Pharmaceuticals Getting Very Oversold (MACK)
April 24, 2013
category Stocks
from Market News Video
8 Biotechnology Stocks to Sell Now
April 17, 2013
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Merrimack Pharmaceuticals (MACK) Completes Enrollment in Phase 2 Study of MM-121 in HER2-Negative Breast Cancer
April 15, 2013
from StreetInsider.com News Articles
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here